Evaluation of the efficacy of Black seed oil in the treatment of Nasal allergic inflammation

Evaluation of the efficacy of Nigella Sativa oil in the treatment of Nasal allergic inflammation

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138806212446N1

Enrollment

Registered

2010-01-09

Start date

2007-01-14

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis. Allergic rhinitis, unspecified

Interventions

Intervention 1: Interventio: 40-80 mg/kg/day to maximum 3 gr of Black seed. Intervention 2: Control: Placebo.

Treatment - Drugs

Placebo

Interventio: 40-80 mg/kg/day to maximum 3 gr of Black seed

Control: Placebo

Eligibility

Sex/Gender

All

Age

15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients aged 15–65 years with allergic rhinitis and no consumption of steroids and antihistamines and decongestants during 4 weeks before the study Exclusion criteria: Patients who use steroids or antihistamines and decongestants during the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
IgE of serum and nasal secretion. Timepoint: at first and one month later. Method of measurement: Laboratory.	—

Secondary

Measure	Time frame
Eosinophil count of serum and nasal secretion. Timepoint: at first and one month later. Method of measurement: Laboratory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoheila Nikakhlagh

Ahwaz Jondishapour University of Medical Sciences

Bioinfo2003@ajums.ac.ir+98 61 1336 2411

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026